Specialty Overview

Best Hospitals for Patent Ductus Arteriosus (PDA) Device Closure in Mumbai, India

17 paediatric cardiology hospitals in our India network are listed in Mumbai, accredited by JCI, NABH, NABL, ISO 9001, with 6,503 beds combined.

17
Hospitals Listed
1
City
4.6
Avg. Rating
4
Accreditation Types
The Short Answer

This page lists the paediatric cardiology hospitals in our directory offering Patent Ductus Arteriosus (PDA) Device Closure in Mumbai, India, including Nanavati Super Specialty Hospital, Kokilaben Dhirubhai Ambani Hospital, Tata Memorial Hospital, Apollo Hospitals, Navi Mumbai and others. Each listing links through to the hospital's full profile page.

Ask us about patent ductus arteriosus (pda) device closure in Mumbai, India

Share a few details and our care coordination team will get back to you with next steps.

Compare 17 accredited hospitals for Paediatric Cardiology in Mumbai, India

🇮🇳 Nanavati Super Specialty Hospital

Mumbai, India 5 (12 reviews) 350 beds
Why consider this hospital?
5/5 rating from 12 reviewsAccredited by JCI, NABH350 beds
Specialties & Accreditation
OncologyCardiac SurgeryNeurosciencesTransplantBariatrics
Accredited by JCI, NABH

Patients considering patent ductus arteriosus (pda) device closure can be cared for by Nanavati Super Specialty Hospital's care team in Mumbai, India, from initial consultation through recovery. Nanavati Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing patent ductus arteriosus (pda) device closure.

5/5
Rating
1950
Established
350
Beds
Mumbai, India
Location
Kokilaben Dhirubhai Ambani Hospital

🇮🇳 Kokilaben Dhirubhai Ambani Hospital

Mumbai, India 4.8 (1800 reviews) 750 beds
Why consider this hospital?
4.8/5 rating from 1800 reviewsAccredited by JCI, NABH750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
Accredited by JCI, NABH

Patients considering patent ductus arteriosus (pda) device closure can be cared for by Kokilaben Dhirubhai Ambani Hospital's care team in Mumbai, India, from initial consultation through recovery. Kokilaben Dhirubhai Ambani Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing patent ductus arteriosus (pda) device closure.

4.8/5
Rating
2009
Established
750
Beds
Mumbai, India
Location
Tata Memorial Hospital

🇮🇳 Tata Memorial Hospital

Mumbai, India 4.8 (2500 reviews) 629 beds
Why consider this hospital?
4.8/5 rating from 2500 reviewsAccredited by NABH629 beds
Specialties & Accreditation
OncologyCancer Center
Accredited by NABH

Patients considering patent ductus arteriosus (pda) device closure can be cared for by Tata Memorial Hospital's care team in Mumbai, India, from initial consultation through recovery. Tata Memorial Hospital, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing patent ductus arteriosus (pda) device closure.

4.8/5
Rating
1941
Established
629
Beds
Mumbai, India
Location
Apollo Hospitals, Navi Mumbai

🇮🇳 Apollo Hospitals, Navi Mumbai

Mumbai, India 4.8 (512 reviews) 500 beds
Why consider this hospital?
4.8/5 rating from 512 reviewsAccredited by JCI, NABH500 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsSpine Surgery
Accredited by JCI, NABH

Patients considering patent ductus arteriosus (pda) device closure can be cared for by Apollo Hospitals, Navi Mumbai's care team in Mumbai, India, from initial consultation through recovery. Apollo Hospitals, Navi Mumbai, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing patent ductus arteriosus (pda) device closure.

4.8/5
Rating
2016
Established
500
Beds
Mumbai, India
Location
Gleneagles Hospital, Mumbai

🇮🇳 Gleneagles Hospital, Mumbai

Mumbai, India 4.8 (615 reviews) 638 beds
Why consider this hospital?
4.8/5 rating from 615 reviewsAccredited by JCI, NABH638 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsGastroenterology
Accredited by JCI, NABH

Patients considering patent ductus arteriosus (pda) device closure can be cared for by Gleneagles Hospital, Mumbai's care team in Mumbai, India, from initial consultation through recovery. Gleneagles Hospital, Mumbai, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing patent ductus arteriosus (pda) device closure.

4.8/5
Rating
2008
Established
638
Beds
Mumbai, India
Location
Lilavati Hospital And Research Centre

🇮🇳 Lilavati Hospital And Research Centre

Mumbai, India 4.8 (724 reviews) 326 beds
Why consider this hospital?
4.8/5 rating from 724 reviewsAccredited by JCI, NABH326 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsGastroenterology
Accredited by JCI, NABH

Patients considering patent ductus arteriosus (pda) device closure can be cared for by Lilavati Hospital And Research Centre's care team in Mumbai, India, from initial consultation through recovery. Lilavati Hospital And Research Centre, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing patent ductus arteriosus (pda) device closure.

4.8/5
Rating
1997
Established
326
Beds
Mumbai, India
Location
Jaslok Hospital

🇮🇳 Jaslok Hospital

Mumbai, India 4.6 (129 reviews) 350 beds
Why consider this hospital?
4.6/5 rating from 129 reviewsAccredited by NABH, NABL350 beds
Specialties & Accreditation
Cardiac SurgeryNeurosciencesOncologyOrthopedicsTransplant
Accredited by NABH, NABL

Patients considering patent ductus arteriosus (pda) device closure can be cared for by Jaslok Hospital's care team in Mumbai, India, from initial consultation through recovery. Jaslok Hospital, accredited by NABH, NABL, follows recognised patient-safety and quality-of-care standards when performing patent ductus arteriosus (pda) device closure.

4.6/5
Rating
1973
Established
350
Beds
Mumbai, India
Location
Gleneagles Global Hospitals (Global Hospitals)

🇮🇳 Gleneagles Global Hospitals (Global Hospitals)

Parel, Mumbai, India 4.6 (183 reviews) 450 beds
Why consider this hospital?
4.6/5 rating from 183 reviewsAccredited by NABH, JCI450 beds
Specialties & Accreditation
Liver TransplantCardiac SurgeryOrthopedicsOncologyNeurosciences
Accredited by NABH, JCI

Patients considering patent ductus arteriosus (pda) device closure can be cared for by Gleneagles Global Hospitals (Global Hospitals)'s care team in Parel, Mumbai, India, from initial consultation through recovery. Gleneagles Global Hospitals (Global Hospitals), accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing patent ductus arteriosus (pda) device closure.

4.6/5
Rating
1996
Established
450
Beds
Parel, Mumbai, India
Location
Medicover Hospital, Navi Mumbai

🇮🇳 Medicover Hospital, Navi Mumbai

Navi Mumbai, India 4.6 (143 reviews) 310 beds
Why consider this hospital?
4.6/5 rating from 143 reviewsAccredited by NABH310 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyOrthopedicsNeurologyGastroenterology
Accredited by NABH

Patients considering patent ductus arteriosus (pda) device closure can be cared for by Medicover Hospital, Navi Mumbai's care team in Navi Mumbai, India, from initial consultation through recovery. Medicover Hospital, Navi Mumbai, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing patent ductus arteriosus (pda) device closure.

4.6/5
Rating
2023
Established
310
Beds
Navi Mumbai, India
Location
KIMS Hospitals, Thane

🇮🇳 KIMS Hospitals, Thane

Mumbai, India 4.6 (58 reviews) 300 beds
Why consider this hospital?
4.6/5 rating from 58 reviewsAccredited by NABH300 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsSpine Surgery
Accredited by NABH

Patients considering patent ductus arteriosus (pda) device closure can be cared for by KIMS Hospitals, Thane's care team in Mumbai, India, from initial consultation through recovery. KIMS Hospitals, Thane, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing patent ductus arteriosus (pda) device closure.

4.6/5
Rating
2025
Established
300
Beds
Mumbai, India
Location
Our Methodology

How we selected these hospitals

A hospital appears on this page when Paediatric Cardiology is among its listed specialties and it is located in Mumbai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Patent Ductus Arteriosus (PDA) Device Closure in Mumbai, India?

Choosing the right hospital for patent ductus arteriosus (pda) device closure is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include paediatric cardiology rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Patent Ductus Arteriosus (PDA) Device Closure

Patent Ductus Arteriosus (PDA) Device Closure is a minimally invasive, catheter-based cardiac procedure that permanently seals an abnormally patent fetal blood vessel connecting the pulmonary artery to the aorta, restoring normal cardiopulmonary circulation without open-heart surgery.

1–3 days (catheterization lab procedure; ICU observation overnight, ward discharge by day 2–3)
Hospital Stay
1–2 weeks (short-haul); 2–3 weeks (long-haul intercontinental flight, pending echo confirmation of device stability and absence of residual shunt)
Total Stay in Country (Fit-to-Fly)
97–99% (transcatheter device closure; surgical ligation approaches 100% in appropriate anatomy)
Success Rate

Clinical Overview

  • The ductus arteriosus is a physiologically essential fetal vascular channel that connects the main pulmonary artery to the descending thoracic aorta, allowing oxygenated placental blood to bypass the fluid-filled, non-functioning fetal lungs.
  • In healthy full-term neonates, this vessel constricts and functionally closes within 12–72 hours of birth, driven by rising arterial oxygen tension, declining prostaglandin E2 levels, and smooth muscle contraction.
  • When this closure fails — a condition termed Patent Ductus Arteriosus — a persistent left-to-right shunt develops, diverting oxygenated blood from the systemic circulation back into the pulmonary circuit.
Full details →

Who is a Candidate?

  • ELIGIBLE PATIENTS — HEMODYNAMIC CRITERIA:
  • Symptomatic PDA of any age with pulmonary-to-systemic flow ratio (Qp:Qs) ≥ 1.5:1 confirmed on cardiac catheterization or Doppler echocardiography
  • Asymptomatic moderate-to-large PDA with evidence of left ventricular volume overload (left atrial enlargement, LV end-diastolic dimension z-score > +2 on echo)
  • Small 'silent' PDA in adults with a history of infective endocarditis or at high endocarditis risk (professional guidelines vary; most centers close these)
  • +20 more

Treatment Options & Approaches

  • PHARMACOLOGICAL CLOSURE (Neonates and Premature Infants Only):

Recovery

  • PHASE 1 — PRE-ARRIVAL CONSULTATION (2–4 weeks before travel):

Risks to be aware of

  • PDA Device Closure via transcatheter approach is one of the safest structural heart interventions in contemporary pediatric cardiology, with major complication rates below 1–2% in high-volume centers.
  • However, patients and families must be counseled on the following procedure-specific risks with intellectual honesty:
Full details →

Why GAF Healthcare

  • GAF Healthcare provides a fully integrated, door-to-door medical tourism coordination service for PDA Device Closure, removing the administrative and logistical burden from patient families so they can focus entirely on their child's health.

Common questions about Patent Ductus Arteriosus (PDA) Device Closure

What is the cost of PDA Device Closure in India versus the UAE?
The total cost of transcatheter PDA Device Closure (catheterization laboratory fee, device cost, anesthesia, hospital stay of 1–3 days, standard medications, and post-procedure echocardiography) ranges from approximately USD 2,500 to USD 5,000 in India at JCI- and NABH-accredited centers such as Narayana Health, Apollo Hospitals, Amrita Institute of Medical Sciences, and Fortis Healthcare. The same procedure at JCI- and DHA/DOH-accredited hospitals in Dubai or Abu Dhabi (Cleveland Clinic Abu Dhabi, Mediclinic City Hospital, American Hospital Dubai, Sheikh Khalifa Medical City) ranges from approximately USD 7,000 to USD 14,000 — reflecting premium infrastructure, higher overheads, and device import costs in the UAE market. India's price advantage of 40–60% does not imply inferior outcomes: India's top congenital cardiac centers perform thousands of PDA closures annually, and clinical success rates are equivalent to leading Western institutions. Additional costs to factor in include the device implant itself (ADO-I or ADO-II devices cost USD 800–2,500 depending on size and supplier; this is usually included in the Indian package quote but should be confirmed), international travel, accommodation, and GAF Healthcare's coordination fee. GAF Healthcare provides a fully itemized, no-hidden-fee treatment quote within 48–72 hours of receiving the patient's medical records.
How long do we need to stay in the country before my child is fit to fly home?
For the vast majority of transcatheter PDA Device Closure cases in children and adults, the treating cardiologist will assess fitness to fly based on three criteria: (1) clinical stability with no procedural complications, (2) echocardiographic confirmation of satisfactory device position with no hemodynamically significant residual shunt, and (3) intact vascular access site healing. For short-haul flights (under 3–4 hours), most patients are cleared to fly at Day 7–10 post-procedure. For long-haul intercontinental flights (5 hours or more — common for patients traveling from Africa, Europe, North America, or Central Asia), we recommend a minimum stay of 14–21 days to allow a repeat echocardiogram at Day 14, confirming device stability and absence of late complications such as hemolysis, device migration, or new arrhythmia. Surgical ligation cases (VATS or open thoracotomy) require a slightly longer observation period of 14–21 days before any air travel, due to the thoracic incision and the small risk of delayed pneumothorax or chylothorax. GAF Healthcare's treating cardiologist issues a formal aviation medical clearance letter with specific recommendations tailored to the patient's anatomy, device used, and recovery trajectory. This letter is essential documentation for airline boarding and international customs if carrying medical device identification cards.
What is the success rate of PDA Device Closure?
Transcatheter PDA Device Closure using contemporary nitinol occluder devices (Amplatzer Duct Occluder I and II, Occlutech Duct Occluder, Piccolo Occluder) achieves a procedural success rate of 97–99% in high-volume congenital cardiac catheterization centers — defined as complete device deployment with satisfactory positioning and no immediate major complication requiring surgical conversion. Complete occlusion (no residual shunt on color Doppler echocardiography) is achieved in approximately 85–90% of patients at 24 hours, rising to 95–98% by 6 months as the device becomes fully endothelialized and any trivial residual shunting seals spontaneously. Surgical PDA ligation (VATS or open thoracotomy) has a closure rate approaching 100% but carries slightly higher complication rates (recurrent laryngeal nerve injury, chylothorax) compared to transcatheter approaches in experienced hands. The long-term prognosis after successful closure is excellent: left ventricular dimensions normalize within 3–6 months, pulmonary artery pressures reduce in the majority of patients with non-severe pre-operative PAH, and patients typically achieve full physical activity without restriction. Patients presenting with established severe pulmonary arterial hypertension (Eisenmenger syndrome, PVRI ≥ 8 Wood units) are not candidates for closure, as sealing the duct in this setting precipitates acute right ventricular failure; these patients are managed with targeted PAH pharmacotherapy (endothelin receptor antagonists, PDE-5 inhibitors, prostacyclin analogs). GAF Healthcare's partner centers perform individualized hemodynamic assessment — including vasoreactivity testing with inhaled nitric oxide — to ensure that only patients who will genuinely benefit from closure undergo the procedure.

How GAF Healthcare Assists in Choosing the Best Hospital for Patent Ductus Arteriosus (PDA) Device Closure in Mumbai, India

Discover the Top Hospitals for Patent Ductus Arteriosus (PDA) Device Closure in Mumbai, India

This page lists 17 accredited paediatric cardiology hospitals in Mumbai, India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Common Questions

Frequently asked questions about patent ductus arteriosus (pda) device closure in Mumbai, India

How many paediatric cardiology hospitals are listed in Mumbai, India?
17 hospitals in our Mumbai, India directory are currently listed for paediatric cardiology including Patent Ductus Arteriosus (PDA) Device Closure.
How do you choose which hospitals to list?
A hospital appears on this page when Paediatric Cardiology is among its listed specialties and it is located in Mumbai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there paediatric cardiology hospitals for this in other India cities?
See the "Hospitals in other cities" links on this page for the full India list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH, NABL, ISO 9001 — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for patent ductus arteriosus (pda) device closure?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about patent ductus arteriosus (pda) device closure in Mumbai, India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for patent ductus arteriosus (pda) device closure in Mumbai, India.

Contact us to report an inaccuracy on this page.